OncoZenge AB (publ) ONCOZ.ST Stock
4.3 SEK
{{ price }}
2.383788%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
Sweden
Exchange
Stockholm
Market Cap
50.31M SEK
LOW - HIGH [24H]
4.04
-
4.3 SEK
VOLUME [24H]
11.63K SEK
{{ volume }}
P/E Ratio
0
Earnings per share
-1.48 SEK
OncoZenge AB (publ) Price Chart
OncoZenge AB (publ) ONCOZ.ST Financial and Trading Overview
| OncoZenge AB (publ) stock price | 4.3 SEK |
| Previous Close | 6.3 SEK |
| Open | 6.08 SEK |
| Bid | 5.99 SEK x N/A |
| Ask | 6.24 SEK x N/A |
| Day's Range | 6 - 6.57 SEK |
| 52 Week Range | 2.11 - 10.56 SEK |
| Volume | 16.57K SEK |
| Avg. Volume | 60.78K SEK |
| Market Cap | 70.28M SEK |
| Beta (5Y Monthly) | 1.62949 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.48 SEK |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 2.5 SEK |
ONCOZ.ST Valuation Measures
| Enterprise Value | 53.4M SEK |
| Trailing P/E | N/A |
| Forward P/E | 5.357143 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 2.3492563 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -6.037 |
Trading Information
OncoZenge AB (publ) Stock Price History
| Beta (5Y Monthly) | 1.62949 |
| 52-Week Change | 155.57% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 10.56 SEK |
| 52 Week Low | 2.11 SEK |
| 50-Day Moving Average | 7.6 SEK |
| 200-Day Moving Average | 5.68 SEK |
ONCOZ.ST Share Statistics
| Avg. Volume (3 month) | 60.78K SEK |
| Avg. Daily Volume (10-Days) | 53.19K SEK |
| Shares Outstanding | 11.71M |
| Float | 8.47M |
| Short Ratio | N/A |
| % Held by Insiders | 52.56% |
| % Held by Institutions | 1.47% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -22.76% |
| Return on Equity (ttm) | -39.46% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -8845000 SEK |
| Net Income Avi to Common (ttm) | -14637000 SEK |
| Diluted EPS (ttm) | -1.46 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 23.79M SEK |
| Total Cash Per Share (mrq) | 2.03 SEK |
| Total Debt (mrq) | 0 SEK |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 14.691 |
| Book Value Per Share (mrq) | 2.554 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -17000000 SEK |
| Levered Free Cash Flow (ttm) | -11511125 SEK |
Profile of OncoZenge AB (publ)
| Country | Sweden |
| State | N/A |
| City | Bromma |
| Address | Gustavslundsvagen 34 |
| ZIP | 167 51 |
| Phone | 46 8 31 14 20 |
| Website | https://www.oncozenge.se |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
OncoZenge AB (publ), a pharmaceutical company, develops treatment for pain relief in patients suffering from oral pain caused by radiation therapy and chemotherapy for cancer in Sweden. It offers BupiZenge, which has completed Phase 2 clinical trial for the treatment of oral mucositis. The company was founded in 2020 and is headquartered in Bromma, Sweden.
Q&A For OncoZenge AB (publ) Stock
What is a current ONCOZ.ST stock price?
OncoZenge AB (publ) ONCOZ.ST stock price today per share is 4.3 SEK.
How to purchase OncoZenge AB (publ) stock?
You can buy ONCOZ.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for OncoZenge AB (publ)?
The stock symbol or ticker of OncoZenge AB (publ) is ONCOZ.ST.
Which industry does the OncoZenge AB (publ) company belong to?
The OncoZenge AB (publ) industry is Biotechnology.
How many shares does OncoZenge AB (publ) have in circulation?
The max supply of OncoZenge AB (publ) shares is 11.71M.
What is OncoZenge AB (publ) Price to Earnings Ratio (PE Ratio)?
OncoZenge AB (publ) PE Ratio is now.
What was OncoZenge AB (publ) earnings per share over the trailing 12 months (TTM)?
OncoZenge AB (publ) EPS is -1.48 SEK over the trailing 12 months.
Which sector does the OncoZenge AB (publ) company belong to?
The OncoZenge AB (publ) sector is Healthcare.
OncoZenge AB (publ) ONCOZ.ST included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| First North Sweden SEK PI FNSESEKPI | 1843.91 SEK 179.99 USD |
-0.28
|
— — | — — | — — | — - | — — |
| First North Sweden EUR PI FNSEEURPI | 1479.5 EUR 1617.29 USD |
-0.77
|
— — | — — | — — | — - | — — |
| First North Health Care PI FN20PI | 912.9 EUR 997.92 USD |
-1.17
|
— — | — — | — — | — - | — — |
| First North All-Share SEK FIRSTNORTHSEK | 123.34 SEK 12.04 USD |
-0.14
|
— — | — — | — — | — - | — — |
| First North All-Share DKK FIRSTNORTHDKK | 97.96 DKK 14.36 USD |
-0.62
|
— — | — — | — — | — - | — — |
| First North Sweden SEK GI FNSESEKGI | 1956.89 SEK 191.02 USD |
-0.28
|
— — | — — | — — | — - | — — |
| First North Sweden EUR GI FNSEEURGI | 1570.14 EUR 1716.38 USD |
-0.77
|
— — | — — | — — | — - | — — |
| First North Health Care GI FN20GI | 917.04 EUR 1002.44 USD |
-1.17
|
— — | — — | — — | — - | — — |
| First North All-Share EUR FIRSTNORTHEUR | 97.9 EUR 107.01 USD |
-0.64
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}